88 related articles for article (PubMed ID: 22002443)
21. Point mutation instability (PIN) mutator phenotype as model for true back mutations seen in hereditary tyrosinemia type 1 - a hypothesis.
van Dyk E; Pretorius PJ
J Inherit Metab Dis; 2012 May; 35(3):407-11. PubMed ID: 22002443
[TBL] [Abstract][Full Text] [Related]
22. Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1.
Aponte JL; Sega GA; Hauser LJ; Dhar MS; Withrow CM; Carpenter DA; Rinchik EM; Culiat CT; Johnson DK
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):641-5. PubMed ID: 11209059
[TBL] [Abstract][Full Text] [Related]
23. Molecular Aspects of the FAH Mutations Involved in HT1 Disease.
Morrow G; Angileri F; Tanguay RM
Adv Exp Med Biol; 2017; 959():25-48. PubMed ID: 28755182
[TBL] [Abstract][Full Text] [Related]
24. Direct sequencing of FAH gene in Pakistani tyrosinemia type 1 families reveals a novel mutation.
Ijaz S; Zahoor MY; Imran M; Afzal S; Bhinder MA; Ullah I; Cheema HA; Ramzan K; Shehzad W
J Pediatr Endocrinol Metab; 2016 Mar; 29(3):327-32. PubMed ID: 26565546
[TBL] [Abstract][Full Text] [Related]
25. Fumarylacetoacetate, the metabolite accumulating in hereditary tyrosinemia, activates the ERK pathway and induces mitotic abnormalities and genomic instability.
Jorquera R; Tanguay RM
Hum Mol Genet; 2001 Aug; 10(17):1741-52. PubMed ID: 11532983
[TBL] [Abstract][Full Text] [Related]
26. DNA replication fidelity and cancer.
Preston BD; Albertson TM; Herr AJ
Semin Cancer Biol; 2010 Oct; 20(5):281-93. PubMed ID: 20951805
[TBL] [Abstract][Full Text] [Related]
27. Aberrant expression of alternative DNA polymerases: a source of mutator phenotype as well as replicative stress in cancer.
Hoffmann JS; Cazaux C
Semin Cancer Biol; 2010 Oct; 20(5):312-9. PubMed ID: 20934518
[TBL] [Abstract][Full Text] [Related]
28. Lethal mutagenesis: targeting the mutator phenotype in cancer.
Fox EJ; Loeb LA
Semin Cancer Biol; 2010 Oct; 20(5):353-9. PubMed ID: 20934515
[TBL] [Abstract][Full Text] [Related]
29. Efficiency of carcinogenesis: is the mutator phenotype inevitable?
Beckman RA
Semin Cancer Biol; 2010 Oct; 20(5):340-52. PubMed ID: 20934514
[TBL] [Abstract][Full Text] [Related]
30. Hereditary tyrosinemia type 1 metabolites impair DNA excision repair pathways.
van Dyk E; Steenkamp A; Koekemoer G; Pretorius PJ
Biochem Biophys Res Commun; 2010 Oct; 401(1):32-6. PubMed ID: 20828540
[TBL] [Abstract][Full Text] [Related]
31. Assessing the DNA methylation status of single cells with the comet assay.
Wentzel JF; Gouws C; Huysamen C; Dyk Ev; Koekemoer G; Pretorius PJ
Anal Biochem; 2010 May; 400(2):190-4. PubMed ID: 20156416
[TBL] [Abstract][Full Text] [Related]
32. DNA polymerase proofreading: Multiple roles maintain genome stability.
Reha-Krantz LJ
Biochim Biophys Acta; 2010 May; 1804(5):1049-63. PubMed ID: 19545649
[TBL] [Abstract][Full Text] [Related]
33. Single-nucleotide mutation rate increases close to insertions/deletions in eukaryotes.
Tian D; Wang Q; Zhang P; Araki H; Yang S; Kreitman M; Nagylaki T; Hudson R; Bergelson J; Chen JQ
Nature; 2008 Sep; 455(7209):105-8. PubMed ID: 18641631
[TBL] [Abstract][Full Text] [Related]
34. CpG dinucleotides and the mutation rate of non-CpG DNA.
Walser JC; Ponger L; Furano AV
Genome Res; 2008 Sep; 18(9):1403-14. PubMed ID: 18550801
[TBL] [Abstract][Full Text] [Related]
35. Cancers exhibit a mutator phenotype: clinical implications.
Loeb LA; Bielas JH; Beckman RA
Cancer Res; 2008 May; 68(10):3551-7; discussion 3557. PubMed ID: 18483233
[TBL] [Abstract][Full Text] [Related]
36. Epigenetics in cancer.
Esteller M
N Engl J Med; 2008 Mar; 358(11):1148-59. PubMed ID: 18337604
[No Abstract] [Full Text] [Related]
37. Hepatic stress in hereditary tyrosinemia type 1 (HT1) activates the AKT survival pathway in the fah-/- knockout mice model.
Orejuela D; Jorquera R; Bergeron A; Finegold MJ; Tanguay RM
J Hepatol; 2008 Feb; 48(2):308-17. PubMed ID: 18093685
[TBL] [Abstract][Full Text] [Related]
38. Mutation as a stress response and the regulation of evolvability.
Galhardo RS; Hastings PJ; Rosenberg SM
Crit Rev Biochem Mol Biol; 2007; 42(5):399-435. PubMed ID: 17917874
[TBL] [Abstract][Full Text] [Related]
39. The stochastic model of non-equilibrium mutagen-induced alterations of DNA: implication to genetic instability in cancer.
Triampo D; Triampo W; Tang IM; Lenbury Y
Biosystems; 2007; 90(3):870-80. PubMed ID: 17597289
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
